[ad_1]
Great Ormond Street Hospital for Children (GOSH) and Roche UK have partnered to develop a digital tool aimed at identifying better ways to care for children and young people with rare and complex diseases.
Building on GOSH’s position as a leader in digital innovation in the NHS, the collaboration uses cutting-edge technologies, such as artificial intelligence (AI) and machine learning, to enable better use of data that will benefit GOSH and beyond. Collected regularly to improve care.
While no patient data is shared, these new tools will allow data to be used securely and in new ways, improving clinical care and the patient experience.
It will optimize the development of innovative new treatments for rare and complex diseases, helping them get from lab to patient more quickly.
Professor Neil Sebiere, Chief Research Information Officer, GOSH’s Data Research, Innovation and Virtual Environments Unit (GOSH DRIVE), said: “We are one of the most digitally advanced hospitals in Europe and have over 170 services for children and young people to care for. Has years of experience with complex health conditions.
“This means we have a tremendous amount of experience and information that can help us find new and better ways to diagnose and treat patients and help us run our hospital.
“But we need new tools to harness the power of this data. Our partnership with Roche UK will help us do this by enhancing our data capabilities and infrastructure.”
This first of its kind collaboration aims to develop a better understanding of how the NHS and pharmaceutical companies can work together to improve patients’ lives.
By enabling the automated analysis of anonymised information – such as genomic data, images and text – tools and clinical workflows can be developed to enhance clinical decision making at scale in the NHS, helping patients Each step of their journey is built upon learnings from each patient previously treated, with the ultimate goal of providing the best possible care to patients.
work with a range of partners
Roche UK will provide funding and other staff to work closely with the GOSH drive. Guided by a steering group of leaders from both organisations, the team will work with other stakeholders such as the public, patients, UK government bodies and healthcare partners, adopting a systems change approach that can generate benefits across the NHS.
All projects undertaken within the partnership are conducted within GOSH’s secure digital research infrastructure and no patient data is shared between organizations or outside GOSH.
Richard Irvine, General Manager of Roche UK, said: “Like GOSH, we are committed to ensuring that patients receive the best possible experience and outcome.
“Through our collaboration, we can show how the NHS and pharma can work together to develop technologies that can be used by the NHS to deploy real world applications that benefit patients and health systems. optimize the use of data already collected within.”
Most recently, Roche UK partnered with digital health technology company Nye Health to create co-digital solutions that learn, personalize and adapt to patient needs outside of the hospital or traditional clinical setting.










